SOURCE: Tulip BioMed, Inc.

June 05, 2007 08:28 ET

Tulip's Proprietary Disposable Products to Be Exhibited at the Multi-Specialty Foundation for Aesthetic Surgical Excellence, Facial Cosmetic Surgery Meeting

Meeting and Exhibition to Be Held June 13-17, 2007 at The Bellagio, Las Vegas, NV; Physicians: Please Visit Tulip at the Bellagio Tower Ballroom, Booth 302, for a Special Discount!

SAN DIEGO, CA--(Marketwire - June 5, 2007) - Tulip BioMed™, Inc. (PINKSHEETS: TPBD), a developer of biodesign instruments for living tissue management, including instruments for plastic, cosmetic, and orthopedic surgeries, announced today that it will demonstrate its disposable, minimally invasive micro-cannulas for tissue harvest, transfer, re-injection and other surgical uses, plus a series of versatile, disposable cannula models (prototypes) that work with both standard aspiration machines and the syringe method for body sculpting, at the Multi-Specialty Foundation for Aesthetic Surgical Excellence (the "Foundation"). Tulip BioMed's products, and additional information about the company, can be accessed at

Physicians who are interested in trying Tulip BioMed's disposable products are encouraged to visit Tulip BioMed at Booth 302 where the company will provide a Tulip BioMed Sample Kit (2 - Injectors of choice, 2 - Harvesters of choice, 1 - Luer-to-Luer connector, 1 - 18 Gauge Sterile Needle, 5 - 1 cc Syringes, and 2 - 10/12 cc Syringes) for $100, after which the company will credit buyers $100 towards their next purchase.

The purpose and mission of the Foundation is to foster a sense of cooperation between the four medical specialties that are primarily involved in the science, practice and teaching of facial aesthetic surgery. The Foundation's main objective is to create a recurring annual symposium that includes leading educators from the fields of Oculoplastic Surgery, Dermatologic Surgery, Facial Plastic Surgery and Plastic Surgery. The Foundation's focus includes full interactive teaching programs with a particular emphasis on facial rejuvenation. Its goal is to continue creating and funding future educational ventures that will benefit today's medical practitioners and students, as well as members of the public at large.

Doctors and industry professionals who would like to discuss the advantages of Tulip BioMed's products are encouraged to call the company at 800-978-8547.

Safe Harbor: This press release contains certain forward-looking information about Tulip BioMed, Inc., which is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "expect(s)," "feel(s)," "believe(s)," "will," "may," "anticipate(s)," and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of Tulip BioMed, Inc., that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: our lack of operating revenue and earnings history, our need for additional capital to pursue our business strategy. We are a non-reporting company and as such do not make periodic filings with the Securities and Exchange Commission. We trade on the Pink Sheets and there can be no assurances that a liquid market will develop in our securities. Readers are cautioned not to place undue reliance on these forward-looking statements. Tulip BioMed, Inc. does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information

    Premier Funding Service
    Kelly Black

    Heather Kerwin
    Investor Relations

    (480) 649-8224 Office
    (480) 898-0406 Fax